Characteristics of Adult Outpatients and Inpatients with COVID-19 - 11 Academic Medical Centers, United States, March-May 2020
- PMID: 32614810
- PMCID: PMC7332092
- DOI: 10.15585/mmwr.mm6926e3
Characteristics of Adult Outpatients and Inpatients with COVID-19 - 11 Academic Medical Centers, United States, March-May 2020
Abstract
Descriptions of coronavirus disease 2019 (COVID-19) in the United States have focused primarily on hospitalized patients. Reports documenting exposures to SARS-CoV-2, the virus that causes COVID-19, have generally been described within congregate settings, such as meat and poultry processing plants (1) and long-term care facilities (2). Understanding individual behaviors and demographic characteristics of patients with COVID-19 and risks for severe illness requiring hospitalization can inform efforts to reduce transmission. During April 15-May 24, 2020, telephone interviews were conducted with a random sample of adults aged ≥18 years who had positive reverse transcription-polymerase chain reaction (RT-PCR) test results for SARS-CoV-2 in outpatient and inpatient settings at 11 U.S. academic medical centers in nine states. Respondents were contacted 14-21 days after SARS-CoV-2 testing and asked about their demographic characteristics, underlying chronic conditions, symptoms experienced on the date of testing, and potential exposures to SARS-CoV-2 during the 2 weeks before illness onset (or the date of testing among those who did not report symptoms at the time of testing). Among 350 interviewed patients (271 [77%] outpatients and 79 [23%] inpatients), inpatients were older, more likely to be Hispanic and to report dyspnea than outpatients. Fewer inpatients (39%, 20 of 51) reported a return to baseline level of health at 14-21 days than did outpatients (64%, 150 of 233) (p = 0.001). Overall, approximately one half (46%) of patients reported known close contact with someone with COVID-19 during the preceding 2 weeks. This was most commonly a family member (45%) or a work colleague (34%). Approximately two thirds (64%, 212 of 333) of participants were employed; only 35 of 209 (17%) were able to telework. These findings highlight the need for screening, case investigation, contact tracing, and isolation of infected persons to control transmission of SARS-CoV-2 infection during periods of community transmission. The need for enhanced measures to ensure workplace safety, including ensuring social distancing and more widespread use of cloth face coverings, are warranted (3).
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Daniel J. Henning reports a grant from Baxter and consulting fees from CytoVale. Akram Khan reports grants from United Therapeutics, Actcelion Pharmaceuticals, Regneron, and Reata Pharmaceuticals. Christopher J. Lindsell reports grants from NIH, DoD, the Marcus Foundation, and data analysis and study coordination contracts with Entergrion, Endpoint Health, and bioMerieux. Courtney N. Sciarratta reports a cooperative agreement between CDC and Public Health Institute. No other potential conflicts of interest were disclosed.
Similar articles
-
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020.MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998. doi: 10.15585/mmwr.mm6930e1. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32730238 Free PMC article.
-
Telework Before Illness Onset Among Symptomatic Adults Aged ≥18 Years With and Without COVID-19 in 11 Outpatient Health Care Facilities - United States, July 2020.MMWR Morb Mortal Wkly Rep. 2020 Nov 6;69(44):1648-1653. doi: 10.15585/mmwr.mm6944a4. MMWR Morb Mortal Wkly Rep. 2020. PMID: 33151918 Free PMC article.
-
First 100 Persons with COVID-19 - Zambia, March 18-April 28, 2020.MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1547-1548. doi: 10.15585/mmwr.mm6942a5. MMWR Morb Mortal Wkly Rep. 2020. PMID: 33090982 Free PMC article.
-
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839. JAMA. 2020. PMID: 32648899 Review.
-
COVID-19: A management update.Cleve Clin J Med. 2023 Nov 1;90(11):677-683. doi: 10.3949/ccjm.90a.22102. Cleve Clin J Med. 2023. PMID: 37914200 Review.
Cited by
-
Ensemble machine learning of factors influencing COVID-19 across US counties.Sci Rep. 2021 Jun 3;11(1):11777. doi: 10.1038/s41598-021-90827-x. Sci Rep. 2021. PMID: 34083563 Free PMC article.
-
Lungs after COVID-19: Evolving Knowledge of Post-COVID-19 Interstitial Lung Disease.Ann Am Thorac Soc. 2021 May;18(5):773-774. doi: 10.1513/AnnalsATS.202102-223ED. Ann Am Thorac Soc. 2021. PMID: 33929309 Free PMC article. No abstract available.
-
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study.Clin Gastroenterol Hepatol. 2021 Jul;19(7):1469-1479.e19. doi: 10.1016/j.cgh.2020.09.027. Epub 2020 Sep 17. Clin Gastroenterol Hepatol. 2021. PMID: 32950749 Free PMC article.
-
Examining spatial inequality in COVID-19 positivity rates across New York City ZIP codes.Health Place. 2021 May;69:102574. doi: 10.1016/j.healthplace.2021.102574. Epub 2021 Apr 17. Health Place. 2021. PMID: 33895489 Free PMC article.
-
Acute COVID-19 gene-expression profiles show multiple etiologies of long-term sequelae.medRxiv [Preprint]. 2021 Oct 5:2021.10.04.21264434. doi: 10.1101/2021.10.04.21264434. medRxiv. 2021. PMID: 34642700 Free PMC article. Preprint.
References
-
- CDC. Coronavirus disease 2019 (COVID-19): recommendations regarding the use of cloth face coverings, especially in areas of significant community-based transmission. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-fac...
-
- Office of the President of the United States. Coronavirus guidelines for America. Washington, DC: Office of the President of the United States; 2020. https://www.whitehouse.gov/briefings-statements/coronavirus-guidelines-a...